PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences Biotech Investing
Nano Dimension and Accellta Joined Forces to Successfully BioPrint Stem Cell-Derived Tissues Emerging Technology Investing
Independent Phase II and III Clinical Studies on 22nd Century's Smoking Cessation Technology Highlighted on New Heracles Website Biotech Investing
PharmaCyte Biotech to Engage Principal Investigator for Clinical Trial in Pancreatic Cancer Biotech Investing
Initial Efficacy Data for GlycoMimetics’ GMI-1271 Combined with Chemotherapy in Patients with AML to Be Presented at European Hematology Association 21st Congress Biotech Investing
Fortress Biotech Presents Positive Data from the Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia at the Innate Killer Summit 2016 Biotech Investing
Biotie Therapies Corp. to Delist Its American Depositary Shares from the Nasdaq Global Select Market Biotech Investing
